EIF2AK2 and hepatocellular carcinoma: Multiple studies have observed increased expression levels and elevated activity of PKR in hepatitis C virus (HCV)-related and -unrelated hepatocellular carcinoma (9–11), as well as in several other cancer cell types, for example, human breast cancer cells (12) and melanoma cells (13,14).